Hydroxychloroquine Seller Again Amends Complaint After Prior Pleading Is Stricken
TRENTON, N.J. — After its second amended complaint (SAC) against a pharmaceutical manufacturer — filed in connection with its purchase of large quantities of hydroxychloroquine and chloroquine phosphate during the COVID-19...To view the full article, register now.
Already a subscriber? Click here to view full article